Comparison of a Commercial Real-Time PCR Assay for tcdB Detection to a Cell Culture Cytotoxicity Assay and Toxigenic Culture for Direct Detection of Toxin-Producing Clostridium difficile in Clinical Samples

作者: P. D. Stamper , R. Alcabasa , D. Aird , W. Babiker , J. Wehrlin

DOI: 10.1128/JCM.01613-08

关键词:

摘要: Rapid detection of toxin-producing strains Clostridium difficile is essential for optimal management patients with C. infection. The BD GeneOhm (San Diego, CA) Cdiff assay, a real-time PCR assay that amplifies tcdB, was compared to cell culture neutralization (Wampole Toxin B [TOX-B] test; TechLab, Blacksburg, VA) and toxigenic culture. Using liquid (n = 273) soft 131) stool specimens from 377 symptomatic patients, all testing performed on the same day by independent laboratory staff according manufacturers' protocols. Toxigenic bacterial as follows. A 0.5-ml aliquot heated 80°C 10 min, followed inoculation onto modified cycloserine cefoxitin fructose agar without horse blood (Remel, Lenexa, KS) into prereduced chopped-meat broth. Of 404 tested, 340 were negative 40 positive (10.0% prevalence) both tcdB cytotoxin production. overall agreement between TOX-B test 94.8% (380/401). When used reference method, initial sensitivity, specificity, predictive values 90.9% (40/44), 95.2% (340/357), 70.2% (40/57), 98.8% (340/344), respectively. “gold standard,” 83.6%, 98.2%, 89.5%, 97.1%, respectively, those 67.2%, 99.1%, 93.2%, 94.4%, PCRs three samples inhibited upon testing; one sample resolved retesting. One produced nonspecific results. well standard directly fecal specimens.

参考文章(31)
C J Shanholtzer, K E Willard, J J Holter, M M Olson, D N Gerding, L R Peterson, Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. Journal of Clinical Microbiology. ,vol. 30, pp. 1837- 1840 ,(1992) , 10.1128/JCM.30.7.1837-1840.1992
C S Merz, C Kramer, M Forman, L Gluck, K Mills, K Senft, I Steiman, N Wallace, P Charache, Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens. Journal of Clinical Microbiology. ,vol. 32, pp. 1142- 1147 ,(1994) , 10.1128/JCM.32.5.1142-1147.1994
R. J. van den Berg, L. S. Bruijnesteijn van Coppenraet, H.-J. Gerritsen, H. P. Endtz, E. R. van der Vorm, E. J. Kuijper, Prospective Multicenter Evaluation of a New Immunoassay and Real-Time PCR for Rapid Diagnosis of Clostridium difficile-Associated Diarrhea in Hospitalized Patients Journal of Clinical Microbiology. ,vol. 43, pp. 5338- 5340 ,(2005) , 10.1128/JCM.43.10.5338-5340.2005
Markus Mehlig, Michael Moos, Veit Braun, Bettina Kalt, David E. Mahony, Christoph Eichel-Streiber, Variant toxin B and a functional toxin A produced by Clostridium difficile C34. Fems Microbiology Letters. ,vol. 198, pp. 171- 176 ,(2001) , 10.1111/J.1574-6968.2001.TB10638.X
Lacey Benson, Xiaoyan Song, Joseph Campos, Nalini Singh, Changing Epidemiology of Clostridium difficile-Associated Disease in Children Infection Control and Hospital Epidemiology. ,vol. 28, pp. 1233- 1235 ,(2007) , 10.1086/520732
L. Kyne, M. B. Hamel, R. Polavaram, C. P. Kelly, Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clinical Infectious Diseases. ,vol. 34, pp. 346- 353 ,(2002) , 10.1086/338260
Judith A. O'Brien, Betsy J. Lahue, J. Jaime Caro, David M. Davidson, The Emerging Infectious Challenge of Clostridium difficile -Associated Disease in Massachusetts Hospitals: Clinical and Economic Consequences Infection Control and Hospital Epidemiology. ,vol. 28, pp. 1219- 1227 ,(2007) , 10.1086/522676
D. M. Musher, A. Manhas, P. Jain, F. Nuila, A. Waqar, N. Logan, B. Marino, E. A. Graviss, Detection of Clostridium difficile Toxin: Comparison of Enzyme Immunoassay Results with Results Obtained by Cytotoxicity Assay Journal of Clinical Microbiology. ,vol. 45, pp. 2737- 2739 ,(2007) , 10.1128/JCM.00686-07
B. Hubert, V. G. Loo, A.-M. Bourgault, L. Poirier, A. Dascal, E. Fortin, M. Dionne, M. Lorange, A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec. Clinical Infectious Diseases. ,vol. 44, pp. 238- 244 ,(2007) , 10.1086/510391